Additionally, we have shown that in bariatric patients, serum LOX is elevated in patients with NAFLD-associated hepatic fibrosis, relative to those without fibrosis [24]. The gene discussed is LOX; the disease is metabolic dysfunction-associated steatotic liver disease.